Polyclonal Antibody to Phosphatidylethanolamine Binding Protein 1 (PEBP1)
| Code | Size | Price |
|---|
| PAG543Mu01-20ul | 20ul | £88.00 |
Quantity:
| PAG543Mu01-100ul | 100ul | £165.00 |
Quantity:
| PAG543Mu01-200ul | 200ul | £223.00 |
Quantity:
| PAG543Mu01-1ml | 1ml | £512.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
PBP; HCNP; PEBP; RKIP; Prostatic Binding Protein; Raf Kinase Inhibitory Protein; Hippocampal Cholinergic Neurostimulating Peptide; Neuropolypeptide h3
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Phosphatidylethanolamine Binding Protein 1
Reactivity:
Hu;Ra;
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-2ug/mL;1:150-650<br/>Immunohistochemistry: 5-20ug/mL;1:15-65<br/>Immunocytochemistry: 5-20ug/mL;1:15-65<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Phosphatidylethanolamine Binding Protein 1 (PEBP1) | RPG543Mu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||